OverviewChartNewsTraderScreen

Morgan Stanley Call 790 LLY 20.09.../  DE000ME8QSE2  /

Stuttgart
7/30/2024  8:37:44 PM Chg.-0.40 Bid10:00:34 PM Ask10:00:34 PM Underlying Strike price Expiration date Option type
2.07EUR -16.19% -
Bid Size: -		 -
Ask Size: -		 ELI LILLY 790.00 - 9/20/2024 Call
TeleTrader 7/8 Eli Lilly launches $3.2B tender offer for Morphic
TeleTrader 7/2 US FDA approves Eli Lilly's Alzheimer's drug
GlobeNewswire 7/1 Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studyi...
GlobeNewswire 6/28 Atossa Therapeutics Announces Updated Protocol for Clinical Trial Evaluating (Z)-Endoxifen in Combin...
TeleTrader 6/25 Lilly partners with OpenAI to combat drug-resistance bacteria
GlobeNewswire 6/21 HUTCHMED Announces European Commission Approval for FRUZAQLA® (fruquintinib) Received by Takeda
GlobeNewswire 6/19 Jasper Therapeutics Announces Appointment of Svetlana Lucas Ph.D., to its Board of Directors
GlobeNewswire 6/17 CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer
GlobeNewswire 6/17 Atossa Set to Join Russell 3000® Index Effective June 28, 2024
GlobeNewswire 6/14 TScan Therapeutics Announces Updates to its Board of Directors
GlobeNewswire 6/12 US Gastroenterologists Express Anticipation for Approval of AbbVie’s Skyrizi in Ulcerative Colitis, ...
GlobeNewswire 6/11 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
GlobeNewswire 6/11 Skyhawk Therapeutics Promotes Clint Musil to Chief Executive Officer and Appoints Co-founder Bill Ha...
GlobeNewswire 6/11 Adverum Biotechnologies Announces Appointments of Dr. Rabia Gurses Ozden as Chief Medical Officer an...
GlobeNewswire 6/11 Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next...
TeleTrader 6/10 FDA advisors endorse Eli Lilly's Alzheimer's drug
Newsfile Corp 6/10 Guest Invitation to Momentum AI Summit in July
GlobeNewswire 6/10 Sermonix Pharmaceuticals Announces Breast Cancer Research Publication of Paper Examining Lasofoxifen...
GlobeNewswire 6/10 RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships
GlobeNewswire 6/6 Sermonix Pharmaceuticals Announces Chinese Approval of Investigational New Drug Application for Laso...
GlobeNewswire 6/6 Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepin...
TeleTrader 6/5 Alphabet appoints Anat Ashkenazi as new CFO
GlobeNewswire 6/4 CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Pres...
GlobeNewswire 6/3 BIOPHTA raises 6.5 million Euros Seed Funding to transition its New Standard of Care for Eye Disease...
GlobeNewswire 6/3 HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine